Leif Kuse: Nudging the industry towards innovation with group purchasing for biotechs
Send us Fan Mail
This week we speak to Leif Kuse, who is Lead Trailblazer of Drug Development Outsourcing Disruption and CEO PHARALL.
We speak about group purchasing for biotechs in clinical trials. We start out by exploring how CRO contracting usually happens for biotechs, where clinical trials are typically outsourced to CROs.
Biotech outsourcing is especially tricky, because in especially smaller companies, there may not be competencies to handle a sudden increase of people working for the company by adding a partner to the organization.
There are several models for collaborating with…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.